Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Use of Cannabidiol for the Treatment of Inflammatory Bowel Disease

NCT01037322 is registered in ClinicalTrials.gov with Meir Medical Center as lead sponsor.

NCT NCT01037322
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01037322 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Use of Cannabidiol for the Treatment of Inflammatory Bowel Disease
Lead sponsor
Meir Medical Center
Phase
Phase 1/2
Overall status
Completed
Start date
January 31, 2010
Completion date
September 30, 2012
Enrollment
20 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

crohn's disease, ulcerative colitis